The ATBioFarm technology facilitates the scalable, single-step production of these sophisticated, highly stable and homogenous biologics, promising significant advancements across various therapeutic applications.
Our patented atbiofarm technology leverages plant expression systems in a truly distinct method of production, avoiding chemical conjugation issues.
The atbiofarm technology is instrumental to the generation of our new atbody format, including payloads with differentiated mode of action, that cannot be generated using classical production systems, such as mammalian and bacterial expression systems.
Insertion of atbody genetic material into a vector
Transfer of genetic material into plants
Plants convert genetic material into protein
Purification of atbodies from plant leaves